Trials / Completed
CompletedNCT05710302
Prospective Validation of the Emergency Heart Failure Mortality Risk Grade (EHMRG) Score in Patients With Acute Heart Failure in the Emergency Department
Investigation of the Diagnostic Accuracy of EHMRG Risk Score in Patients With Acute Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 239 (actual)
- Sponsor
- Marmara University Pendik Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this prospective validation study, researchers investigates accuracy of EHMRG (Emergency Heart Failure Mortality Risk Grade) score in predicting the 7th and 30th day risk of mortality in patients with acute heart failure who applying to the emergency department.
Detailed description
Heart failure is a serious public health problem in the world due to its high morbidity and mortality rate.Turkish Society of Cardiology conducted a prevalence study. The name of the study is HAPPY. Accordingly, the prevalence of heart failure in people over 35 years of age in Turkey is 2.9%.The prevalence of heart failure in Turkey is higher than in European countries. The incidence of heart failure cases with no obvious symptoms is 4.9% in Turkey. Patients with a diagnosis of heart failure apply to the emergency department frequently. There are scoring studies around the world for patients' hospitalization and discharge. EHMRG score created and validated by Douglas S. Lee et al. In our study, the accuracy of EHMRG score will be investigated prospectively in patients diagnosed with acute heart failure in the emergency department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Investigation of the diagnostic accuracy of EHMRG risk score in patients with acute heart failure | Prospective validation of the EHMRG score in patients with acute heart failure in the emergency department |
Timeline
- Start date
- 2022-07-29
- Primary completion
- 2022-09-03
- Completion
- 2023-01-24
- First posted
- 2023-02-02
- Last updated
- 2023-02-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05710302. Inclusion in this directory is not an endorsement.